Board of Directors
30th Floor, Pacific Century Place Marunouchi
11-1 Marunouchi 1-Chome
Member of the Board
Aki Watanabe is founder and Representative Director of GCA Corporation. He has over 30 years of M&A advisory experience and has completed numerous domestic and cross-border deals including the sale of Japan Tobacco’s beverage business to Suntory, sale of Daiichi Sankyo’s listed Indian generics manufacturer Rambaxy Laboratories to Sun Pharma, consolidation of the thermal power businesses of Hitachi Ltd and Mitsubishi Heavy Industries, Advantest’s acquisition of Verigy, Carlyle’s sale of its pharmaceutical capsule business to Mitsubishi Chemical Holdings, Citigroup’s acquisition of Nikko Cordial Group, merger of JVC and Kenwood, Ricoh’s acquisition of IBM’s printing solutions subsidiary, merger of Sankyo and Daiichi Pharmaceutical, among others.
He is currently an independent director of FamilyMart UNY Holdings Co., Ltd, Qualicaps Co., Ltd (Mitsubishi Chemical Holdings subsidiary), and Maruho Co., Ltd.
He previously served as independent director and Auditing Committee chairman of Ranbaxy Laboratories Ltd, an independent director of Samson Investment Company and a member of the Board of Trustees of the International Valuation Standards Council.
Aki’s previous work experiences include Peat Marwick Mitchell & Co. (current KPMG LLP) NY Office (1982) and Representative Director of KPMG Corporate Finance (1994). GCA was founded in April 2004, and was listed on the Tokyo Stock Exchange Mothers in 2006. In 2008, GCA was integrated with US Savvian and was listed on TSE First Section in September 2012.
He is a visiting professor at the MBA program of Kobe University and has published many books on M&A and related topics. Aki received his BA in Commerce and Accounting from Chuo University and is a CPA in Japan and the US.